Teva Pharmaceutical Industries Ltd
Close on Nov 18, 2026Market cap $49.21BP/E 70.4Yield –
Teva Pharmaceutical Industries Teva API (TAPI) by Quarter
Teva API (TAPI) — Active Pharmaceutical Ingredient Sales to Third Parties ($M)
Teva Pharmaceutical Industries Teva API (TAPI): $115M in Q3 2026, down 8.0% from a year earlier.
Where the Q3 2026 figure comes from
“API sales to third parties in the third quarter of 2026 were $115 million, a decrease of 8% in both U.S. dollars and local currency terms, compared to the third quarter of 2025. This decrease was mainly due to lower dema”
Source: Form 8-K Earnings Release (0001171843-26-007054) ↗
Third-party revenues of Teva Active Pharmaceutical Ingredients (TAPI), one of the world's leading suppliers of APIs.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up teva API (TAPI)
Cite this data
StockData. (2026). Teva Pharmaceutical Industries Teva API (TAPI) ($M), quarterly Q1 2018–Q3 2026 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/sub-tapi-rev
See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.
See a number that looks wrong?